A clinical site for advancing treatments in neurological diseases.
Clinical Research Site for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT site)
This study is looking for ways to turn new research into helpful treatments for people with neurological disorders, and it invites patients to join clinical trials that could lead to exciting new therapies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10894833 on NIH RePORTER |
What this research studies
This research focuses on translating new preclinical findings into effective treatments for patients suffering from various neurological disorders. The project is part of the Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT), which conducts Phase 2 clinical trials and biomarker validation studies. Northwestern University's Feinberg School of Medicine collaborates with multiple hospitals to leverage their resources and expertise, ensuring a diverse patient population is involved in the trials. Patients may have the opportunity to participate in innovative clinical trials that could lead to new therapies.
Who could benefit from this research
Good fit: Ideal candidates include individuals aged 21 and older with various neurological conditions who are seeking new treatment options.
Not a fit: Patients with neurological diseases that are not included in the trial protocols may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective treatments for neurological diseases.
How similar studies have performed: Previous research within the NeuroNEXT framework has shown promise in advancing treatment options for neurological conditions, indicating a successful track record.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Simuni, Tanya — Northwestern University at Chicago
- Study coordinator: Simuni, Tanya
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.